Paid Clinical Trials for Schizophrenia

Showing 21 – 40 of 46 results

Assessment of Schizophrenia Patients’ Clinical Study Experiences

by CTG

in Schizophrenia

Other

California

Deadline:

08/01/2026

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

by CTG

in Schizophrenia, Schizo Affective Disorder

Other

Pennsylvania

Deadline:

06/01/2026

Mobile Thinking Intervention: A Inital Test

by CTG

in Schizophrenia, Clinical High Risk for Psychosis (CHR)

Other

Alabama

Deadline:

12/01/2028

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

by CTG

in Schizophrenia, Apathy, Schizophrenia; Psychosis

Other

Louisiana

Deadline:

12/01/2026

Enhancing Rehabilitation for Veterans With Serious Mental Illness

by CTG

in PTSD, Psychosis, Schizophrenia, Schizoaffective Disorder, Serious Mental Illness

Other

California

Deadline:

10/31/2028

Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

by CTG

in Schizophrenia, Depressive Disorder, Major, Bipolar Disorder, Stress Disorder, Post-Traumatic

Other

Minnesota

Deadline:

11/30/2027

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

by CTG

in Schizophrenia, Bipolar I Disorder

Other

Arkansas

Deadline:

11/30/2026

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

by CTG

in Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder

Other

California

Deadline:

05/31/2028

EPI-MINN: Targeting Cognition and Motivation – National

by CTG

in Psychosis, Schizophrenia, Schizoaffective Disorder, Schizo Affective Disorder, Psychosis Nos/Other

Other

Minnesota

Deadline:

06/30/2026

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

by CTG

in Major Depressive Disorder, Schizophrenia, Traumatic Brain Injury, Attention Deficit Hyperactivity Disorder, Bipolar Disorder

Other

Massachusetts

Deadline:

04/01/2026

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

by CTG

in Schizophrenia

Other

Arkansas

Deadline:

02/01/2028

Song-making In a Group (SING)

by CTG

in Schizophrenia

Other

Connecticut

Deadline:

05/31/2026

A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia

by CTG

in Schizophrenia

Other

California

Deadline:

10/15/2027

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

by CTG

in Cannabis Use, Psychosis, Schizophrenia, Marijuana, THC

Other

Connecticut

Deadline:

12/01/2026

Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation

by CTG

in Schizophrenia

Other

Pennsylvania

Deadline:

06/01/2028

Effectiveness of Motivation Skills Training (MST)

by CTG

in Schizophrenia, Schizoaffective Disorder

Other

New York

Deadline:

11/30/2026

Treating Schizophrenia by Correcting Abnormal Brain Development

by CTG

in Schizophrenia

Other

Massachusetts

Deadline:

09/01/2026

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

by CTG

in Schizophrenia, Bipolar I Disorder

Other

Alabama

Deadline:

09/01/2027

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

by CTG

in Schizophrenia

Other

Arizona

Deadline:

02/27/2026

Load more All clinical trials loaded.

Assessment of Schizophrenia Patients’ Clinical Study Experiences

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

Mobile Thinking Intervention: A Inital Test

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Enhancing Rehabilitation for Veterans With Serious Mental Illness

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

EPI-MINN: Targeting Cognition and Motivation – National

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

Song-making In a Group (SING)

A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation

Effectiveness of Motivation Skills Training (MST)

Treating Schizophrenia by Correcting Abnormal Brain Development

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Schizophrenia

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps